Wednesday, 26 August 2026European Markets

ENSURGE MICROPOWER Stock Was Up By 10.71% Today

Loading stream...

(VIANEWS) - The Market ended the session with ENSURGE MICROPOWER (ENSU.OL) jumping 10.71% to kr0.16 on Wednesday while Oslo Børs Benchmark Index_GI dropped 0.14% to kr1,289.59.

ENSURGE MICROPOWER's last close was kr0.14, 96.66% below its 52-week high of kr4.19.

About ENSURGE MICROPOWER

Ensurge Micropower ASA manufactures and sells ultrathin energy storage solutions for wearable devices, connected sensors, and other applications. Its solid-state lithium battery technology enables it to produce rechargeable batteries. The company was formerly known as Thin Film Electronics ASA and changed its name to Ensurge Micropower ASA in June 2021. Ensurge Micropower ASA was incorporated in 2005 and is headquartered in Oslo, Norway.

Earnings Per Share

As for profitability, ENSURGE MICROPOWER has a trailing twelve months EPS of kr-0.52.

Moving Average

ENSURGE MICROPOWER's worth is way above its 50-day moving average of kr0.12 and way below its 200-day moving average of kr0.76.

Volatility

ENSURGE MICROPOWER's last week, last month's, and last quarter's current intraday variation average was 4.00%, 1.85%, and 3.50%.

ENSURGE MICROPOWER's highest amplitude of average volatility was 5.72% (last week), 3.80% (last month), and 3.50% (last quarter).

Volume

Today's last reported volume for ENSURGE MICROPOWER is 61820400 which is 184.53% above its average volume of 21726900.

Earnings Before Interest, Taxes, Depreciation, and Amortization

ENSURGE MICROPOWER's EBITDA is -150.46.

More news about ENSURGE MICROPOWER (ENSU.OL).

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
AI Leadership Exodus Rattles Investor Confidence Amid Capex Boom
High-profile departures at top AI labs — Brad Lightcap's exit from OpenAI and an unnamed researcher's departure from Alphabet/Google that triggered a share-price drop — are surfacing talent retention as a market risk factor even as hyperscalers pour record capital into AI infrastructure. The reaction shows investors treating key-person risk at frontier AI labs as material to valuation, a new fragility layered onto an otherwise bullish AI-driven capex cycle.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Broadcom Inc.
Both facts report EPS for Broadcom Inc. for the same fiscal period (Q1 2026) observed on the same date (2026-02-01). However, they report conflicting values: 1.5 USD per share vs 2.05 USD per share. This is a 37% difference for the identical metric and time period, not a value change over time.
We flag conflicts openly ›
Recently verified
Checked against the original source
4,978
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,978 facts checked against source5,251 source documents archived
Query this data → isubstrate.com